Adlai Nortye Ltd. (ANL)
NASDAQ: ANL · Real-Time Price · USD
14.80
-0.11 (-0.74%)
At close: Apr 24, 2026, 4:00 PM EDT
14.52
-0.28 (-1.89%)
After-hours: Apr 24, 2026, 7:55 PM EDT
Adlai Nortye Market Cap
Adlai Nortye has a market cap or net worth of $592 million as of April 24, 2026. Its market cap has increased by 682.56% in one year.
Market Cap
592.00M
Enterprise Value
609.42M
1-Year Change
682.56%
Ranking
Category
Stock Price
$14.80
Market Cap Chart
Since the IPO on September 29, 2023, Adlai Nortye's market cap has increased from $553.50M to $592.00M, an increase of 6.96%. That is a compound annual growth rate of 2.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 592.00M | 1,029.81% |
| Dec 31, 2025 | 52.40M | -47.12% |
| Dec 31, 2024 | 99.08M | -70.13% |
| Dec 29, 2023 | 331.73M | -40.07% |
| Sep 29, 2023 | 553.50M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gyre Therapeutics | 705.86M |
| Prime Medicine | 701.24M |
| Tenax Therapeutics | 700.18M |
| Arvinas | 679.91M |
| First Tracks Biotherapeutics | 655.71M |
| ProKidney | 631.00M |
| Eikon Therapeutics | 628.01M |
| Kyverna Therapeutics | 619.22M |